Internal Medicine · Dayville, CT
NPI
1982766325
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
612 Hartford Pike
Dayville, CT, 06241
Phone (860) 779-0867
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
1,561 services
Medicare patients, 2024
255
Average age 75
Drug cost, 2024
$5.9M
16,847 prescriptions
Company payments, 2025
$4,444
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee S Wesler was code 99214 (office e&m - established), 601 times for 219 patients. In total Lee S Wesler billed 1,561 services in 34 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 601 | 219 | $85.86 | $52K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 316 | 172 | $12.19 | $3,851 |
| 93000 Electrocardiogram | Office | 139 | 121 | $10.53 | $1,463 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 88 | 88 | $134.80 | $12K |
| 99213 Office E&M - Established | Office | 62 | 49 | $66.40 | $4,117 |
| 99211 Office E&M - Established | Office | 51 | 12 | $15.43 | $787 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 32 | 27 | $42.30 | $1,354 |
| G0008 Administration of influenza virus vaccine | Office | 28 | 28 | $33.90 | $949 |
| 90662 Vaccine Product | Office | 25 | 25 | $81.82 | $2,046 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 16 | 15 | $232.82 | $3,725 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 13 | 13 | $171.03 | $2,223 |
| 99212 Office E&M - Established | Office | 12 | 12 | $35.49 | $426 |
By year: 2022 $76K for 1,298 services; 2023 $72K for 1,175 services; 2024 $94K for 1,561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lee S Wesler prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,005 prescriptions and refills. In total Lee S Wesler wrote 16,847 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,005 | 2,581 | 245 | $8,201 |
| Ozempic Semaglutide | 688 | 893 | 119 | $875K |
| Rosuvastatin Calcium Generic | 554 | 1,509 | 170 | $7,699 |
| Jardiance Empagliflozin | 512 | 1,115 | 123 | $643K |
| Amlodipine Besylate Generic | 482 | 1,189 | 129 | $3,064 |
| Lisinopril Generic | 466 | 1,139 | 121 | $2,547 |
| Eliquis Apixaban | 379 | 638 | 73 | $368K |
| Metformin Hcl Er Metformin Hcl | 362 | 784 | 89 | $4,023 |
| Olmesartan Medoxomil Generic | 356 | 879 | 116 | $4,333 |
| Mounjaro Tirzepatide | 353 | 404 | 60 | $438K |
| Levothyroxine Sodium Generic | 351 | 827 | 78 | $3,044 |
| Carvedilol Generic | 346 | 825 | 85 | $2,961 |
| Gabapentin Generic | 272 | 383 | 58 | $4,188 |
| Omeprazole Generic | 237 | 504 | 60 | $3,730 |
| Repatha Sureclick Evolocumab | 226 | 307 | 37 | $173K |
Brand drugs: 4,512 claims; generic drugs: 12,210 claims; opioid claims: 290.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee S Wesler $4,444 ($4,444 in general payments such as food, travel and fees) from 29 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $590.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 23 | $590 |
| Teva Pharmaceuticals USA, Inc. TEVA | 16 | $492 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $456 |
| Novo Nordisk Inc NVO | 14 | $403 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $378 |
| Abbvie Inc. ABBV | 15 | $298 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $187 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $180 |
| Pfizer Inc. PFE | 9 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.